Spectrascience Inc. announced that its Board of Directors has appointed Rand Mulford to its Board. Rand is an independent consultant with a depth of experience in assisting organizations in developing overall strategy and conducting corporate financing and development programs. For the past five years, Mr. Mulford has successfully completed a variety of projects including managing M&A transactions, developing strategy for companies in therapeutic antibodies, cell-based therapy for eye diseases, prescription drug distribution, and developing a potential cure for AIDS. Previously, Mr. Mulford had joined with two other partners to found a specialty pharmaceutical company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.97K | |
+11.91% | 227B | |
+15.46% | 197B | |
+18.58% | 141B | |
+30.36% | 110B | |
+0.65% | 64.15B | |
+17.74% | 53.72B | |
+5.82% | 51.75B | |
+11.23% | 45.2B | |
+5.73% | 37.37B |
- Stock Market
- Equities
- SCIE Stock
- News SpectraScience, Inc.
- Spectrascience Inc. Appoints Rand Mulford to its Board